News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Conference News NY Valves 2025 No Benefit of Sentinel Device During TAVI: Updated Meta-analysis Todd Neale July 04, 2025
News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018
News Conference News SCAI 2017 New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke L.A. McKeown May 12, 2017
News Conference News ACC 2017 Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI Caitlin E. Cox March 20, 2017